Literature DB >> 2209258

Behavioural pharmacology of nicotine: implications for multiple brain nicotinic receptors.

I P Stolerman1.   

Abstract

Behavioural studies can contribute to the characterization of receptors for psychoactive drugs, and attempts have been made to link behavioural effects of nicotinic agonists with the high affinity binding site for [3H] nicotine. Cueing (discriminative stimulus) effects of drugs enable trained humans or animals to recognize when a specific drug is administered. There was a correlation between the potencies of some compounds in the binding procedure and their ability to produce the nicotine discriminative stimulus in rats, supporting the view that the high affinity binding site was a functional receptor. Nicotine also produced complex changes in locomotor activity of rats, characterized acutely by transient depression and chronically by persistent stimulation. The abilities of nicotinic compounds to produce these locomotor effects were not always consistent with the studies on binding and the nicotine discriminative stimulus. Some compounds were relatively more potent in producing locomotor depression or stimulation than the discriminative effect. Some compounds also failed to produce chronic locomotor activation at doses that produced discriminative and acute depressant effects. These findings may be interpreted as preliminary evidence that different behavioural effects of nicotine may be mediated through different mechanisms, possibly involving multiple subtypes of nicotinic receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2209258     DOI: 10.1002/9780470513965.ch2

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  7 in total

1.  Rapid sensitization of physiological, neuronal, and locomotor effects of nicotine: critical role of peripheral drug actions.

Authors:  Magalie Lenoir; Jeremy S Tang; Amina S Woods; Eugene A Kiyatkin
Journal:  J Neurosci       Date:  2013-06-12       Impact factor: 6.167

2.  Behavioural effects of the nicotinic agonists N-(3-pyridylmethyl)pyrrolidine and isoarecolone in rats.

Authors:  C Reavill; J A Waters; I P Stolerman; H S Garcha
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Attenuated nicotine-like effects of varenicline but not other nicotinic ACh receptor agonists in monkeys receiving nicotine daily.

Authors:  Colin S Cunningham; Megan J Moerke; Martin A Javors; F Ivy Carroll; Lance R McMahon
Journal:  Br J Pharmacol       Date:  2016-11-06       Impact factor: 8.739

4.  Differential induction of ethanol-metabolizing CYP2E1 and nicotine-metabolizing CYP2B1/2 in rat liver by chronic nicotine treatment and voluntary ethanol intake.

Authors:  Jiang Yue; Jibran Khokhar; Sharon Miksys; Rachel F Tyndale
Journal:  Eur J Pharmacol       Date:  2009-03-13       Impact factor: 4.432

5.  Regulation of nicotinic receptors in rat brain following quasi-irreversible nicotinic blockade by chlorisondamine and chronic treatment with nicotine.

Authors:  H el-Bizri; P B Clarke
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

6.  Effects of nicotine on depressive-like behavior and hippocampal volume of female WKY rats.

Authors:  Yousef Tizabi; Sheketha R Hauser; Khandra Y Tyler; Bruk Getachew; Reza Madani; Yukti Sharma; Kebreten F Manaye
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-10-01       Impact factor: 5.067

Review 7.  Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.

Authors:  Maryka Quik; Danhui Zhang; Xiomara A Perez; Tanuja Bordia
Journal:  Pharmacol Ther       Date:  2014-05-14       Impact factor: 12.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.